Geode Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-494,234
| Closed | -$4.64M | – | 4335 |
|
|
2020
Q3 | $4.64M | Sell |
494,234
-5,682
| -1% | -$54K | ﹤0.01% | 2434 |
|
|
2020
Q2 | $3.82M | Sell |
499,916
-571
| -0.1% | -$4.37K | ﹤0.01% | 2493 |
|
|
2020
Q1 | $3.09M | Buy |
500,487
+25,861
| +5% | +$228K | ﹤0.01% | 2427 |
|
|
2019
Q4 | $5.78M | Buy |
474,626
+16,607
| +4% | +$181K | ﹤0.01% | 2362 |
|
|
2019
Q3 | $5.29M | Buy |
458,019
+1,353
| +0.3% | +$14.2K | ﹤0.01% | 2352 |
|
|
2019
Q2 | $4.56M | Sell |
456,666
-18,421
| -4% | -$199K | ﹤0.01% | 2458 |
|
|
2019
Q1 | $6.12M | Buy |
475,087
+40,282
| +9% | +$600K | ﹤0.01% | 2215 |
|
|
2018
Q4 | $6.6M | Sell |
434,805
-683
| -0.2% | -$13K | ﹤0.01% | 2052 |
|
|
2018
Q3 | $8.71M | Buy |
435,488
+31,038
| +8% | +$707K | ﹤0.01% | 2029 |
|
|
2018
Q2 | $7.88M | Buy |
404,450
+34,894
| +9% | +$772K | ﹤0.01% | 2056 |
|
|
2018
Q1 | $7.45M | Sell |
369,556
-7,923
| -2% | -$134K | ﹤0.01% | 1981 |
|
|
2017
Q4 | $5M | Buy |
377,479
+5,452
| +1% | +$82.2K | ﹤0.01% | 2215 |
|
|
2017
Q3 | $6.86M | Buy |
372,027
+8,709
| +2% | +$162K | ﹤0.01% | 2005 |
|
|
2017
Q2 | $6.68M | Buy |
363,318
+830
| +0.2% | +$16.4K | ﹤0.01% | 1948 |
|
|
2017
Q1 | $8.17M | Buy |
362,488
+56,493
| +18% | +$1.35M | ﹤0.01% | 1758 |
|
|
2016
Q4 | $10.6M | Buy |
305,995
+15,010
| +5% | +$448K | 0.01% | 1523 |
|
|
2016
Q3 | $7.13M | Buy |
290,985
+7,336
| +3% | +$183K | ﹤0.01% | 1718 |
|
|
2016
Q2 | $6.78M | Buy |
283,649
+20,801
| +8% | +$477K | ﹤0.01% | 1697 |
|
|
2016
Q1 | $6.15K | Buy |
262,848
+10,067
| +4% | +$239K | ﹤0.01% | 1738 |
|
|
2015
Q4 | $7.63M | Buy |
252,781
+17,850
| +8% | +$577K | ﹤0.01% | 1570 |
|
|
2015
Q3 | $9.33M | Buy |
234,931
+36,722
| +19% | +$2.28M | 0.01% | 1391 |
|
|
2015
Q2 | $13.7M | Buy |
198,209
+25,241
| +15% | +$1.59M | 0.01% | 1198 |
|
|
2015
Q1 | $9.45M | Buy |
172,968
+43,113
| +33% | +$2.05M | 0.01% | 1432 |
|
|
2014
Q4 | $5.53M | Buy |
129,855
+3,133
| +2% | +$113K | ﹤0.01% | 1750 |
|
|
2014
Q3 | $4.04M | Buy |
126,722
+2,213
| +2% | +$47.2K | ﹤0.01% | 1897 |
|
|
2014
Q2 | $2.58M | Buy |
124,509
+4,165
| +3% | +$77K | ﹤0.01% | 2218 |
|
|
2014
Q1 | $2.33M | Buy |
120,344
+3,230
| +3% | +$68.6K | ﹤0.01% | 2247 |
|
|
2013
Q4 | $2.84M | Buy |
117,114
+7,825
| +7% | +$184K | ﹤0.01% | 2090 |
|
|
2013
Q3 | $2.35M | Buy |
109,289
+2,971
| +3% | +$70.2K | ﹤0.01% | 2074 |
|
|
2013
Q2 | $2.37M | Buy |
+106,318
| New | +$2.34M | ﹤0.01% | 1942 |
|
Geode Capital Management's AMAG Position: Q4 2020 in Review
Geode Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 494,234 shares — an estimated $4.64M sold.
Geode Capital Management first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $13.7M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Geode Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Geode Capital Management sold 494,234 AMAG Pharmaceuticals shares in Q4 2020, an estimated $4.64M.
- Geode Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Geode Capital Management's AMAG Pharmaceuticals position peaked at $13.7M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.